[Arterial hypertension in elderly individuals].
EMERIAU STUDY IN ELDERLY HYPERTENSIVE PATIENTS: This multicenter, randomized, double-blind European study was conducted in 524 elderly patients of mean aged 72 years in three parallel treatment arms (indapamid SR 1.5 mg, amlopidine 5 mg hydrochlorothiazide 25 mg). The study demonstrated an equivalent antihypertensive effect for the three treatment arms and with a mean reduction in diastolic pressure of 23 mmHg. In the indapamid SR group, the rate of normalization was higher, both for elevated systolic-diastolic pressure and elevated systolic pressure, alone. HYVET STUDY: This is an ongoing randomized, double-blind trial designed to confirm the beneficial effect of antihypertensive treatment with indapamid SR in very elderly patients (> 80 years old).
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D017311:Amlodipine / Q000008:administration & dosage / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D007190:Indapamide / Q000008:administration & dosage / Q000627:therapeutic use*; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D017311:Amlodipine; D007190:Indapamide
Hypertension artérielle du sujet âgé.